IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i2p937-d1025148.html
   My bibliography  Save this article

Profile of Drug Utilization in Patients with Rare Diseases in Tuscany, Italy: A Population-Based Study

Author

Listed:
  • Francesca Gorini

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy)

  • Michele Santoro

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy)

  • Anna Pierini

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy
    Fondazione Gabriele Monasterio CNR-Regione Toscana, 56124 Pisa, Italy)

  • Lorena Mezzasalma

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy)

  • Silvia Baldacci

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy)

  • Alessio Coi

    (Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy)

Abstract

Patients with rare diseases (RDs) generally have delayed diagnosis and misdiagnosis, which lead to inappropriate care or the need to modify treatment during the course of the disease. The medical care of RD patients can be further complicated by the presence of comorbidities. In this population-based study, we evaluated the prevalence, intensity of use, and consumption of drugs prescribed to RD patients residing in Tuscany (Italy) in the years 2008–2018. Data from the Registry of Rare Diseases of Tuscany were integrated with information retrieved from regional pharmaceutical prescription databases. The overall prevalence of drug use in the RD patients was 85.4%. Drugs for the alimentary tract and metabolism and antiinfectives for systemic use showed the highest prevalence of use, while drugs for the nervous system had the highest intensity of use only in the pediatric patients. The adults exhibited a female preponderance in terms of the prevalence of use and drug consumption in almost all the age groups and therapeutic categories. Conversely, a higher prevalence of use was observed in the male children. These results provide relevant insights into drug profiles in RD patients, representing a first step for future analyses to monitor changes in drug utilization in patients with RDs over time.

Suggested Citation

  • Francesca Gorini & Michele Santoro & Anna Pierini & Lorena Mezzasalma & Silvia Baldacci & Alessio Coi, 2023. "Profile of Drug Utilization in Patients with Rare Diseases in Tuscany, Italy: A Population-Based Study," IJERPH, MDPI, vol. 20(2), pages 1-14, January.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:937-:d:1025148
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/2/937/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/2/937/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Valentina Orlando & Sara Mucherino & Ilaria Guarino & Francesca Guerriero & Ugo Trama & Enrica Menditto, 2020. "Gender Differences in Medication Use: A Drug Utilization Study Based on Real World Data," IJERPH, MDPI, vol. 17(11), pages 1-10, June.
    2. Silvia Baldacci & Michele Santoro & Anna Pierini & Lorena Mezzasalma & Francesca Gorini & Alessio Coi, 2022. "Healthcare Burden of Rare Diseases: A Population-Based Study in Tuscany (Italy)," IJERPH, MDPI, vol. 19(13), pages 1-12, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ángel Denche-Zamorano & Miguel Ángel Garcia-Gordillo & Raquel Pastor-Cisneros & Nicolás Contreras-Barraza & Jorge Carlos-Vivas & Alexis Colmenarez-Mendoza & José Carmelo Adsuar-Sala, 2022. "Relationship between Physical Activity and Medicine Use in the Spanish Population," Sustainability, MDPI, vol. 14(20), pages 1-11, October.
    2. Cristina Gimenez-Lozano & Lucía Páramo-Rodríguez & Clara Cavero-Carbonell & Francisca Corpas-Burgos & Aurora López-Maside & Sandra Guardiola-Vilarroig & Oscar Zurriaga, 2022. "Rare Diseases: Needs and Impact for Patients and Families: A Cross-Sectional Study in the Valencian Region, Spain," IJERPH, MDPI, vol. 19(16), pages 1-16, August.
    3. Kevin Bliek-Bueno & Sara Mucherino & Beatriz Poblador-Plou & Francisca González-Rubio & Mercedes Aza-Pascual-Salcedo & Valentina Orlando & Mercedes Clerencia-Sierra & Ignatios Ioakeim-Skoufa & Enrico , 2021. "Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy," IJERPH, MDPI, vol. 18(22), pages 1-10, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:937-:d:1025148. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.